Serial measures of microparticles during intense physical activity in untrained subjects with different endothelial abnormalities: new useful biomarkers for individual evaluation?

Abstract

Get full access to this article

View all access options for this article.

References

Boulanger

Amabile

Tedgui

et al.

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48: 180–186.

Nozaky

Sugiyama

Koga

et al.

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. JACC 2009; 54: 601–608.

Sinning

J-M

Losch

Walenta

et al.

Circulating CD311/Annexin V1 microparticles correlate with cardiovascular outcomes. Eur Heart J 2011; 32: 2034–2041.

Giannella

Radu

Franco

et al.

Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance. Cardiovasc Diabetol 2017; 16: 1–10.

Sossdorf

Otto

Claus

et al.

Cell-derived microparticles promote coagulation after moderate exercise. Med Sci Sports Exerc 2011; 43: 1169–1176.

Bittencourt

CRO

Izar

MCO

Nunes

et al.

Effects of chronic exercise on endothelial progenitor cells and microparticles in professional runners. Arq Bras Cardiol 2017; 108: 212–216.

Schwarz

Düsing

Liman

et al.

Marathon running increases circulating endothelial- and thrombocyte-derived microparticles. Prev Cardiol 2018; 25: 317–324.

Walenta

Schwarz

Schirmer

et al.

Circulating microparticles as indicators of peripartum cardiomyopathy. Eur Heart J 2012; 33: 1469–1479.

Strulovici-Barel

Staudt

Krause

et al.

Persistence of circulating endothelial microparticles in COPD despite smoking cessation. Thorax 2016; 71: 1137–1144.

10.

Hargett

Bauer

. On the origin of microparticles: from “platelet dust” to mediators of intercellular communication. Pulm Circ 2013; 3: 329–340.